Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Jarolim

Showing results (121-130 of 187) with videos related to

Pageof 19
Sort By:
Circulation|July 19, 2021
Combining High-Sensitivity Troponin With the American Heart Association/American College of Cardiology Cholesterol Guidelines to Guide Evolocumab TherapyNicholas A Marston, Kazuma Oyama, Petr Jarolim, et al.
Biomarker Research|May 29, 2026
The actively secreted plasma extracellular vesicle troponin (ASPECT) study: circulating troponin in extracellular vesicles across cardiovascular disease cohortsMichail Spanos, Priyanka Gokulnath, Aarush Singh, et al.
Circulation|March 2, 2017
Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care)Matthew A Cavender, William B White, Petr Jarolim, et al.
The Journal of Clinical Investigation|May 5, 2010
Statin-induced Krüppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responsesDe-xiu Bu, Margarite Tarrio, Nir Grabie, et al.
European Journal of Heart Failure|March 29, 2023
Serial assessment of biomarkers and heart failure outcomes in patients with atrial fibrillationKazuma Oyama, Robert P Giugliano, Christian T Ruff, et al.
Journal of the American College of Cardiology|August 24, 2019
Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT TrialArman Qamar, Robert P Giugliano, Erin A Bohula, et al.
American Journal of Hematology|November 26, 2010
Allelic variations in CYP2B6 and CYP2C19 and survival of patients receiving cyclophosphamide prior to myeloablative hematopoietic stem cell transplantationStacy E F Melanson, Kristen Stevenson, Haesook Kim, et al.
JAMA|December 15, 2005
Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery diseaseDavid A Morrow, James A de Lemos, Michael A Blazing, et al.
Chest|April 12, 2007
Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edemaDimitri Karmpaliotis, Ajay J Kirtane, Christopher P Ruisi, et al.
Journal of the American College of Cardiology|July 16, 2016
Serial Cardiac Troponin Measured Using a High-Sensitivity Assay in Stable Patients With Ischemic Heart DiseaseMarc P Bonaca, Ryan G O'Malley, Petr Jarolim, et al.
Pageof 19

Showing results (121-130 of 187) with videos related to

Sort By:
Pageof 19
Circulation|July 19, 2021
Combining High-Sensitivity Troponin With the American Heart Association/American College of Cardiology Cholesterol Guidelines to Guide Evolocumab TherapyNicholas A Marston, Kazuma Oyama, Petr Jarolim, et al.
Biomarker Research|May 29, 2026
The actively secreted plasma extracellular vesicle troponin (ASPECT) study: circulating troponin in extracellular vesicles across cardiovascular disease cohortsMichail Spanos, Priyanka Gokulnath, Aarush Singh, et al.
Circulation|March 2, 2017
Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care)Matthew A Cavender, William B White, Petr Jarolim, et al.
The Journal of Clinical Investigation|May 5, 2010
Statin-induced Krüppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responsesDe-xiu Bu, Margarite Tarrio, Nir Grabie, et al.
European Journal of Heart Failure|March 29, 2023
Serial assessment of biomarkers and heart failure outcomes in patients with atrial fibrillationKazuma Oyama, Robert P Giugliano, Christian T Ruff, et al.
Journal of the American College of Cardiology|August 24, 2019
Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT TrialArman Qamar, Robert P Giugliano, Erin A Bohula, et al.
American Journal of Hematology|November 26, 2010
Allelic variations in CYP2B6 and CYP2C19 and survival of patients receiving cyclophosphamide prior to myeloablative hematopoietic stem cell transplantationStacy E F Melanson, Kristen Stevenson, Haesook Kim, et al.
JAMA|December 15, 2005
Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery diseaseDavid A Morrow, James A de Lemos, Michael A Blazing, et al.
Chest|April 12, 2007
Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edemaDimitri Karmpaliotis, Ajay J Kirtane, Christopher P Ruisi, et al.
Journal of the American College of Cardiology|July 16, 2016
Serial Cardiac Troponin Measured Using a High-Sensitivity Assay in Stable Patients With Ischemic Heart DiseaseMarc P Bonaca, Ryan G O'Malley, Petr Jarolim, et al.
Pageof 19